MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP), a pharmaceutical development company dedicated to improving the lives of patients by developing therapeutics in the areas of oncology, diabetes and obesity, today announced that its financial statements for the year ended June 30, 2006, contained in its Annual Report on Form 20-F for the year ended June 30, 2006, as filed with the Securities and Exchange Commission on December 28, 2006, included an audit report containing a going concern qualification from its independent public accounting firm.
